Nierenzentrum Wiesbaden
Industry / private company
Location:
Wiesbaden,
Germany (DE)
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease (2025)
Bakker WM, Heerspink HJ, Berger SP, Wanner C, Badve SV, Arnott C, Abrahams AC, et al.
Journal article
Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension [Kommentar zu den Leitlinien (2018) der Europäischen Gesellschaft für Kardiologie (ESC) und der Europäischen Gesellschaft für Hypertonie (ESH) für das Management der arteriellen Hypertonie] (2019)
Mahfoud F, Boehm M, Bongarth CM, Bosch R, Schmieder R, Schunkert H, Stellbrink C, et al.
Journal article, Review article
Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on themanagement of arterial hypertension (2019)
Mahfoud F, Boehm M, Bongarth CM, Bosch R, Schmieder R, Schunkert H, Stellbrink C, et al.
Journal article, Editorial